Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 445, 354-355 (25 January 2007) | doi:10.1038/445354a; Published online 24 January 2007
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Research Assistant Professor, Post-Doctoral Fellow, Statistical Genetic Analyst, and Scientific Programmer Positions in Statistical Human Genetics
- University of Michigan
- Ann Arbor, Michigan, USA
Science Officer
- Earth System Science Partnership (ESSP)
- Paris France
Crunch time for multiple-gene tests
Abstract
Sophisticated new genetic tests face an uncertain future — unless they can win clear-cut approval from regulators, insurers and, most importantly, doctors. Virginia Gewin reports.
For many of the women who will learn this year that they have early-stage breast cancer, chemotherapy won't do any good. And a sophisticated genetic test is already available that might help to predict who they are.
To read this story in full you will need to login or make a payment (see right).
